Rare diseases
Investigational molecules
Locations
Study on Dapagliflozin for Heart Failure Patients After a Heart Attack
FranceStudy on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes
BelgiumStudy Comparing Orforglipron and Dapagliflozin for Adults with Type 2 Diabetes and Poor Blood Sugar Control on Metformin
GermanyStudy of Orforglipron for Adults with Type 2 Diabetes and Poor Blood Sugar Control on Insulin Glargine, with or without Metformin and/or SGLT-2 Inhibitor
RomaniaStudy on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis
BelgiumStudy on Preventing Acute Kidney Injury in Cardiac Surgery Patients Using Dapagliflozin
The NetherlandsStudy on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin
BulgariaStudy on the Effects of Dapagliflozin for Patients with Aortic Stenosis Undergoing Valve Replacement
DenmarkStudy on the Safety and Effects of AZD9550 for Overweight and Obese Patients with Non-Alcoholic Steatohepatitis (NASH) with or without Type 2 Diabetes
AustriaStudy on the Effect of Dapagliflozin in Reducing Proteinuria in Patients with Chronic Kidney Disease After Kidney Transplant
FranceStudy on Dapagliflozin for Kidney Protection in Heart Transplant Patients
The NetherlandsStudy on the Safety and Effectiveness of Atrasentan for Patients with IgA Nephropathy Taking SGLT2 Inhibitors
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
